Modefication of the drug-induced tolerance induction to large animals
Modefication of the drug-induced tolerance induction to large animals
批准号:
10470277
负责人:
YASUI Hisataka
金额:
$8.06万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Post-transplant cardiac allograft vasculopathy (CAV) is a key manifestation of chronic rejection in heart transplant recipients and impairs long-term graft outcome. In the present study, we have investigated whether CAB can be prevented by the treatment of cyclophosphamide (CP)-induced tolerance in a murine CAV model of H-2 matched AKR (H-2ィイD2kィエD2 ; Thy1.1, M1s-1ィイD2aィエD2) into C3H (H-2ィイD2kィエD2 ; Thy1.1, M1s-1ィイD2bィエD2) mice. When C3H mice were grafted with H-2 matched AKR heart grafts (HG), most of AKR HG survived over 100 days, but all were rejected within 260 days after grafting. CAV developed in all AKR HG. When C3H mice were primed I.e. with1x10ィイD28ィエD2 AKR(H-2k_) spleen cells (SC) and treated I.p. with 200mg/kg CP, the survival of AKR hearts was prolonged permanently in tolerogen-specific fashion, as observed in that of AKR skins. By this treatment, both minimal degree of mixed chimerism and clonal destruction of M1s-1ィイD2aィエD2-reactive CD4+Vβ6+T cells in the periphery were o … More bserved. Furthermore, post-transplant CAV did not develop in the grafted AKR hearts. When AKR SC and 100mg/kg CP were used as the conditioning, AKR HG were accepted permanently, but survival of AKR skin grafts was mildly prolonged. The clonal destruction of CD4+Vβ6+T cells was induced in the periphery. A minimal degree of mixed chimerism was detective at 4 weeks after AKR SC and 100mg/kg CP treatment, but hardly became detectable at 20 weeks. In the AKR HG of C3H mice treated with AKR SC and 100mg/kg CP, post-transplant CAV did not develop, either. Second set skin grafts from donor AKR mice survived in a tolerogen-specific fashion over 100 days in 10/10 C3H mice treated with AKR SC and 200mg/kg CP and accepting AKR HG over 200 days, and 8/10 C3H mice treated with AKR SC and 100 mg CP and accepting AKR HG over 200 days. In order to further elucidate the nature of tolerance induced with AKR SC and CP, PCR assay was performed. Neither Th1 (IL-2, g-IFN) nor Th2 (IL-4, IL-10) cytokines were accumulated at 4 weeks post-heart grafting in the AKR HG of tolerant C3H mice treated with both AKR SC and 200mg/kg CP and AKR SC and 100mg/kg CP.These results indicate that the suboptimal conditioning (SC+100mg/kg CP) of CP-induced tolerance with 1x10ィイD28ィエD2 SC and 100 mg/kg CP can permit heart allograft without the development of CAV or accumulation of mRNAs for Th1 or Th2 cytokines. Furthermore, the induction of skin allograft tolerance is more difficult than the prevention of post-transplant CAV. Less
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Zhang QW: "Fractionated dosing of cyclophosphamide for establishing long-lasting skin allograft survival, stable mi chimerism and intrathymic clonal deletion in mice primed with allogeneic spleen cells" Transplantation. 63・11. 1667-1673 (1997)
张QW:“环磷酰胺的分次给药,用于在用同种异体脾细胞引发的小鼠中建立持久的皮肤同种异体移植存活、稳定的mi嵌合和胸腺内克隆删除”63・11 1667-1673。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
富田幸裕: "シクロホスファミド誘導性免疫寛容" 現代医療. 30・9. 2291-2299 (1998)
富田幸宏:“环磷酰胺诱导的免疫耐受”现代医学30・9。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yoshikawa, M: "Inability of cyclophosphamide to permit pluripotent stem cell engraftment in cyclophosphamide-induced tolerance."Immunobiology. (in press). (in press) (1999)
Yoshikawa,M:“在环磷酰胺诱导的耐受性中,环磷酰胺无法允许多能干细胞植入。”免疫生物学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 17 条
Establishment of drug-induced tolerance for heart transplantation in large animals
-
批准号:12470242
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.15万
-
财政年份:2000
-
负责人:YASUI Hisataka
-
依托单位:
Analysis of immunological mechanism and inhibition of post-transplant coronary artery disease in mice.
-
批准号:08457304
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.1万
-
财政年份:1996
-
负责人:YASUI Hisataka
-
依托单位:
Heart preservation and immunological tolerance induction in orthotopic heart transplantation in swines.
-
批准号:03454335
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$0.64万
-
财政年份:1991
-
负责人:YASUI Hisataka
-
依托单位:
海外基金